Giebel Godwin Denk, Speckemeier Christian, Abels Carina, Börchers Kirstin, Wasem Jürgen, Blase Nikola, Neusser Silke
Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany.
QM BÖRCHERS CONSULTING+, Herne, Germany.
JMIR Res Protoc. 2022 Apr 21;11(4):e32702. doi: 10.2196/32702.
The use of mobile health (mHealth) apps is increasing rapidly worldwide. More and more institutions and organizations develop regulations and guidelines to enable an evidence-based and safe use. In Germany, mHealth apps fulfilling predefined criteria (Digitale Gesundheitsanwendungen [DiGA]) can be prescribed and are reimbursable by the German statutory health insurance scheme. Due to the increasing distribution of DiGA, problems and barriers should receive special attention.
This study aims to identify the relevant problems and barriers related to the use of mHealth apps fulfilling the criteria of DiGA.
This scoping review will follow published methodological frameworks and the PRISMA-Scr (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews) criteria. Electronic databases (MEDLINE, EMBASE, PsycINFO, and JMIR), reference lists of relevant articles, and grey literature sources will be searched. Two reviewers will assess the eligibility of the articles by a two-stage (title and abstract as well as full text) screening process. Only problems and barriers related to mHealth apps fulfilling the criteria of DiGA are included for this research. The identified studies will be categorized and analyzed with MAXQDA.
This scoping review gives an overview of the available evidence and identifies research gaps regarding problems and barriers related to DiGA. The results are planned to be submitted to an indexed, peer-reviewed journal in the first quarter of 2022.
This is the first review to identify the problems and barriers related to the use of mHealth apps fulfilling the German definition of DiGA. Nevertheless, the findings can be applied to other contexts and health care systems as well.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/32702.
移动健康(mHealth)应用程序在全球范围内的使用正在迅速增加。越来越多的机构和组织制定法规和指南,以实现循证且安全的使用。在德国,符合预定义标准的移动健康应用程序(数字健康应用程序[DiGA])可以被开出处方,并由德国法定医疗保险计划报销。由于DiGA的分发日益增加,问题和障碍应受到特别关注。
本研究旨在确定与使用符合DiGA标准的移动健康应用程序相关的相关问题和障碍。
本范围综述将遵循已发表的方法框架和PRISMA-Scr(系统评价和Meta分析扩展的范围综述的首选报告项目)标准。将搜索电子数据库(MEDLINE、EMBASE、PsycINFO和JMIR)、相关文章的参考文献列表以及灰色文献来源。两名评审员将通过两阶段(标题和摘要以及全文)筛选过程评估文章的合格性。本研究仅纳入与符合DiGA标准的移动健康应用程序相关的问题和障碍。所确定的研究将使用MAXQDA进行分类和分析。
本范围综述概述了现有证据,并确定了与DiGA相关的问题和障碍方面的研究空白。结果计划于2022年第一季度提交给一本索引式同行评审期刊。
这是第一项确定与使用符合德国DiGA定义的移动健康应用程序相关的问题和障碍的综述。尽管如此,这些发现也可应用于其他背景和医疗保健系统。
国际注册报告识别号(IRRID):DERR1-10.2196/32702。